1.25mg Mounjaro — the dose people ask about most

Why does 1.25mg Mounjaro keep coming up if it doesn't exist in the UK?

The most likely explanation is crossover from compounded semaglutide, which has been widely discussed online and in the press, compounding pharmacies in some countries have dispensed semaglutide at 1.25mg. Another source is the ozempic/semaglutide maintenance starting dose of 0.25mg, which gets misread or mistranscribed in forums. And because tirzepatide is sold in the US under the brand name Zepbound (the US brand name; it does not exist as a UK product), some US dosing discussions bleed into UK searches.

The six strengths of genuine UK Mounjaro (as listed in the licensed Summary of Product Characteristics on the eMC) are 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg. Each pen contains enough medicine for four once-weekly injections. If you want a fuller breakdown of why 1.25mg Mounjaro does not exist as a licensed UK presentation, that page explains the search pattern and what to look for instead. If a seller is offering something labelled as 1.25mg Mounjaro, that is a serious red flag: the MHRA has warned publicly that counterfeit weight-loss pens have been found in the UK supply chain, some containing entirely wrong substances. Any medicine that does not match the licensed presentations should be reported at the MHRA's Yellow Card reporting service.

If you want to understand the genuine licensed product more broadly, our Mounjaro overview covers how it works, who it is licensed for, and what to expect.

What is the 2.5mg starter dose actually doing?

The 2.5mg pen is the one every patient starts on, and it has a specific job that is nothing to do with weight loss. Its purpose is tolerability. Tirzepatide works partly by slowing how quickly the stomach empties food, and that action (if introduced too abruptly at a treatment dose) tends to cause significant nausea, vomiting and digestive discomfort. Starting at 2.5mg gives your system time to adjust over the first four weeks before the prescriber reviews whether you are ready to step up.

This is a deliberately gradual design. The NHS tirzepatide medicines page describes the dose escalation as a step process guided by tolerability, and the prescriber, not the patient, decides when each step happens. Some people stay at a lower dose for longer because their side-effect profile warrants it; others progress more quickly. Neither outcome means anything has gone wrong. The important practical habit: if you are starting treatment and feel uncertain whether a symptom is normal, check the Patient Information Leaflet that comes with your pen, it takes under a minute to scan the side-effects list and see whether what you are experiencing is listed.

If the 2.5mg starting dose is what you are specifically comparing between suppliers, our page on the 2.5mg tirzepatide dose goes into more detail about what to expect in that first month.

Who decides when to move from the starter dose to a higher one?

Every dose increase is a prescriber decision, not something a patient schedules for themselves. At nume, a GPhC-registered Independent Prescriber (a real clinician, not automated software) reviews your progress before any repeat or dose change is issued. That review looks at how you have been tolerating the current pen, whether there are any new health considerations, and whether a higher dose is appropriate at that point.

NICE's appraisal of tirzepatide (TA1026) notes that continuing treatment is reviewed if less than 5% weight loss has occurred after six months at the highest tolerated dose. That framing is useful because it shows that the goal is to reach the dose that is both tolerable and effective for you individually, not simply the highest dose possible. The titration schedule in the licensed prescribing information runs in four-week steps from 2.5mg upward; from the 5mg step onward you are at doses that carry genuine therapeutic weight. You can read more about the higher end of the schedule on our page about the 3.75mg query, which addresses a similar search pattern and explains the adjacent licensed steps.

The cost of treatment across different doses is a reasonable practical question at this stage. For current pricing context, our Mounjaro cost page explains how private treatment is structured and what a transparent price should include.

Can I request a specific dose when I consult?

You can absolutely share your preferences and concerns during your consultation, that is what the consultation is for. A prescriber will consider your starting BMI, any relevant health conditions, your previous experience with weight-loss treatment if applicable, and your tolerance history. What they cannot do is prescribe a dose that does not exist in the UK licensed schedule, or skip the starter phase because you feel ready to jump ahead.

If you are transferring from treatment at another provider, evidence of your current dose will be requested so the prescriber can assess what is appropriate next. That evidence-check step is part of how responsible prescribing works, it is not a bureaucratic hurdle but a safeguard. For a fuller picture of how the consultation and clinical review process works at a regulated online pharmacy, our guide to getting Mounjaro online safely walks through each step. And if you have broader questions about treatment options, our weight-loss treatments overview covers the medicines currently licensed in the UK for weight management.

When you're ready to speak to a prescriber about which dose and which medicine is right for you, start your free consultation with our clinical team.